1. Home
  2. RDY vs OI Comparison

RDY vs OI Comparison

Compare RDY & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • OI
  • Stock Information
  • Founded
  • RDY 1984
  • OI 1903
  • Country
  • RDY India
  • OI United States
  • Employees
  • RDY N/A
  • OI N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • OI Containers/Packaging
  • Sector
  • RDY Health Care
  • OI Consumer Discretionary
  • Exchange
  • RDY Nasdaq
  • OI Nasdaq
  • Market Cap
  • RDY 2.1B
  • OI 2.0B
  • IPO Year
  • RDY N/A
  • OI N/A
  • Fundamental
  • Price
  • RDY $15.23
  • OI $14.02
  • Analyst Decision
  • RDY Strong Buy
  • OI Buy
  • Analyst Count
  • RDY 2
  • OI 8
  • Target Price
  • RDY $16.95
  • OI $15.88
  • AVG Volume (30 Days)
  • RDY 1.7M
  • OI 1.0M
  • Earning Date
  • RDY 07-28-2025
  • OI 07-29-2025
  • Dividend Yield
  • RDY 0.63%
  • OI N/A
  • EPS Growth
  • RDY 1.47
  • OI N/A
  • EPS
  • RDY 0.79
  • OI N/A
  • Revenue
  • RDY $3,809,801,863.00
  • OI $6,505,000,000.00
  • Revenue This Year
  • RDY $10.24
  • OI $1.90
  • Revenue Next Year
  • RDY N/A
  • OI $1.28
  • P/E Ratio
  • RDY $19.24
  • OI N/A
  • Revenue Growth
  • RDY 16.61
  • OI N/A
  • 52 Week Low
  • RDY $12.26
  • OI $9.23
  • 52 Week High
  • RDY $16.89
  • OI $14.34
  • Technical
  • Relative Strength Index (RSI)
  • RDY 55.04
  • OI 61.21
  • Support Level
  • RDY $15.16
  • OI $13.48
  • Resistance Level
  • RDY $16.17
  • OI $13.90
  • Average True Range (ATR)
  • RDY 0.20
  • OI 0.36
  • MACD
  • RDY -0.07
  • OI -0.00
  • Stochastic Oscillator
  • RDY 39.74
  • OI 91.67

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

Share on Social Networks: